Article Details

Mirati Therapeutics, Inc. (NASDAQ:MRTX) Given Consensus Rating of "Buy" by Analysts

Retrieved on: 2021-06-29 07:07:30

Tags for this article:

Click the tags to see associated articles and topics

Mirati Therapeutics, Inc. (NASDAQ:MRTX) Given Consensus Rating of "Buy" by Analysts. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 4,573,591 shares of the biotechnology company's stock worth $783,456,000 after purchasing an additional 293,179 shares ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up